| Ashley Thomas, MD | |
|
1012 Lucerne Ter, Orlando, FL 32806-1015 | |
| (401) 423-1039 | |
| (407) 425-2347 |
| Full Name | Ashley Thomas |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 21 Years |
| Location | 1012 Lucerne Ter, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578714135 | NPI | - | NPPES |
| 006677200 | Medicaid | FL | |
| ME106204 | Other | FL | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME106204 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orlando Health | Orlando, FL | Hospital |
| Adventhealth Orlando | Orlando, FL | Hospital |
| Orlando Health South Lake Hospital | Clermont, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.
Health officials in the Philippines have issued a warning to the public regarding the crucifixion and self-flagellation rituals which abound at Easter.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard - an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Scientists have identified a new molecule that inhibits proliferation of a broad range of lethal malignant glioma cells in vitro and in vivo.
› Verified 3 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.
Health officials in the Philippines have issued a warning to the public regarding the crucifixion and self-flagellation rituals which abound at Easter.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard - an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Scientists have identified a new molecule that inhibits proliferation of a broad range of lethal malignant glioma cells in vitro and in vivo.
› Verified 3 days ago
| Entity Name | Orlando Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568693554 PECOS PAC ID: 7719026251 Enrollment ID: O20091123000506 |
News Archive
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.
Health officials in the Philippines have issued a warning to the public regarding the crucifixion and self-flagellation rituals which abound at Easter.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard - an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Scientists have identified a new molecule that inhibits proliferation of a broad range of lethal malignant glioma cells in vitro and in vivo.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Thomas, MD 1012 Lucerne Ter, Orlando, FL 32806-1015 Ph: (401) 423-1039 | Ashley Thomas, MD 1012 Lucerne Ter, Orlando, FL 32806-1015 Ph: (401) 423-1039 |
News Archive
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.
Health officials in the Philippines have issued a warning to the public regarding the crucifixion and self-flagellation rituals which abound at Easter.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard - an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Scientists have identified a new molecule that inhibits proliferation of a broad range of lethal malignant glioma cells in vitro and in vivo.
› Verified 3 days ago
Vamsi Kiran Kodumuri, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 258 S Chickasaw Trl Ste 203, Orlando, FL 32825 Phone: 407-303-6588 | |
Francoeur Cadet, D.O Infectious Disease Medicare: Medicare Enrolled Practice Location: 232 N Orange Blossom Trl, Orlando, FL 32805 Phone: 407-428-5751 Fax: 407-447-7245 | |
Andrija Vidic, D.O Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2415 N Orange Ave Ste 700, Orlando, FL 32804 Phone: 407-303-2474 Fax: 407-303-0680 | |
Azin Azarfar, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 3400 Quadrangle Blvd, Orlando, FL 32817 Phone: 407-266-3627 Fax: 407-266-4911 | |
Zain Zamir, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2501 N Orange Ave Ste 235, Orlando, FL 32804 Phone: 407-303-7169 | |
Dr. Arsenio R Rodriguez, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1745 N Mills Avenue, Orlando, FL 32803 Phone: 407-841-7151 Fax: 407-648-2259 | |
Dr. Maria R Flores, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 70 W Gore St, Suite 100, Orlando, FL 32806 Phone: 407-426-8484 Fax: 404-426-8575 |